United Therapeutics (UTHR) Total Liabilities (2009 - 2026)

United Therapeutics (UTHR) has 18 years of Total Liabilities data on file, last reported at $813.1 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 13.2% year-over-year to $813.1 million; the trailing twelve-month figure through Mar 2026 stood at $813.1 million (down 13.2% YoY), and the FY2025 full-year result was $783.8 million, down 14.8% from the prior year.
• Total Liabilities advanced to $813.1 million in Q1 2026, from $783.8 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $1.3 billion in Q3 2023 to a low of $734.4 million in Q2 2025.
• A 5-year average of $1.1 billion and a median of $1.2 billion in 2024 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities gained 7.55% in 2023 and fell 28.42% in 2025, its largest moves.
• Tracing UTHR's Total Liabilities over 5 years: stood at $1.2 billion in 2022, then fell by 5.26% to $1.2 billion in 2023, then dropped by 22.18% to $920.0 million in 2024, then fell by 14.8% to $783.8 million in 2025, then advanced by 3.74% to $813.1 million in 2026.
• Business Quant data shows UTHR's Total Liabilities at $813.1 million in Q1 2026, $783.8 million in Q4 2025, and $760.9 million in Q3 2025.